Cyclerion Therapeutics (CYCN)
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimula...
- Open
- 4.530
- High
- 4.530
- Low
- 4.080
- Prev. Close
- 4.960
- Volume
- 104.03K
- Turnover
- 448.37K
- Avg Price
- 4.310
- Bid/Ask Ratio
- --
- Amplitude
- 9.07%
- 52wk High
- 8.480
- Volume Ratio
- 4.58
- Turnover Ratio
- 2.89%
Cyclerion Therapeutics Analyst Rating
View moreForecast & Rating
Feb 23, 2026Price forecast
$8.0088.24%
Forecast & Rating-
0analysts
News
- benzinga_article · Sep 4 at 12:05 PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
- PUBT · Aug 27 at 10:10 AM
Cyclerion Therapeutics held shareholder meeting, quorum met
- PUBT · Aug 26 at 11:12 AM
Cyclerion sets Sept. 4 record date for CVR distribution tied to Korsana merger
- Global Report · Aug 25 at 10:12 AM
Wall Street's Leftover Chips: Who's Pivoting and Who's Pretending?
- PUBT · Aug 4 at 09:18 PM
Cyclerion FY26 Q2 net loss widens to $1.76 million; revenue falls to no revenue
